Symbols

TBPH

Theravance·NASDAQ

--(--)

TBPH Profile

Theravance Biopharma, Inc.

A biopharmaceutical company that developing small molecule medicines in the areas of infections, CNS/pain, respiratory disease

Industry

Pharmaceutical

Established Date

Listing Date

05/16/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.theravance.com

Security Type

Common stock

Office address

901 Gateway Boulevard South San Francisco CA 94080

Business

Introduction

Theravance Biopharma, Inc., was registered as a Cayman Islands exempted company limited by shares in July 2013. The company is a biopharmaceutical company focused on drug discovery, development and commercialization. The company's core purpose is to create drugs that can change people's lives. The company used decades of expertise to develop the FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease.